Using natural language processing and machine learning to identify patients at high risk of potentially preventable carbapenem-resistant Enterobacterales (CRE) infection
AGENCY FOR HEALTHCARE RESEARCH AND QUALITY
· United States · $1.24M USD
We use cookies to keep your session secure, remember your preferences, and analyse site traffic with Google Analytics.
By continuing to use GrantFunds you agree to our
Privacy Policy
and
Terms of Use.